Torrent Pharmaceuticals said it has fully repaid secured redeemable non-convertible debentures (NCDs) of Rs 240 crore on 24 March 2020.
Shares of Torrent Pharmaceutical declined 3.54% to Rs 1,754.80. The scrip was trading in the range of Rs 1,713.80 to Rs 1,821.50 so far.
The company's consolidated net profit jumped 77% to Rs 419.39 crore in Q3 December 2019 from Rs 236.96 crore in Q3 December 2018. Net sales declined by 5.4% to Rs 3079 crore in Q3 December 2019 from Rs 3253.50 crore in Q3 December 2018.
Torrent Pharmaceuticals manufactures bulk drugs and pharmaceutical formulations.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)